An expanded universe of stakeholders–including payers, policy makers, physicians, and patients–all share in the responsibility for defining the clinical, economic, and societal value of today’s revolutionary new treatments. Accordingly, our team works with clients on reimbursement and market access strategy to provide a better understanding of the current and future landscape in order to better align, support, and demonstrate evidence of product value to ensure commercial adoption and excellence.